Renovaro will Establish the GEDi CUBE Next Generation Nvidia Blackwell Cluster with Nebul's certified AI Healthcare Cloud solutionsLOS ANGELES, ...

Renovaro will Establish the GEDi CUBE Next Generation Nvidia Blackwell Cluster with Nebul's certified AI Healthcare Cloud solutions LOS ANGELES, Dec. 20, 2024) a leading AI cloud infrastructure compan ...

Liver cancer, one of the leading causes of cancer-related deaths worldwide, has seen a steady rise in both diagnosis and ...

The prevalence of cancer is escalating at an alarming rate globally, underscoring the need for robust diagnostic solutions. Factors such as growing awareness, supportive government initiatives, and ...

Grail needs time to establish its liquid biopsy testing approach in the marketplace, and most importantly, to ensure its ...

AI-driven tools for prescreening patients, predicting responses and outcomes, and guiding patient therapy are maturing and entering the market.

Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA. Luis E. Raez, MD, medical director and chief scientific officer at ...

Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward ...

BioView Ltd. , a company developing advanced medical imaging systems for cancer cell detection, traded on the Tel Aviv Stock Exchange, today announced the completion of the first stage of its joint ...

Guardant Health (GH) announced a collaboration with Boehringer Ingelheim to pursue the regulatory approval and commercialization of the ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

LMNTIC Biotech develops liquid biopsy technology to isolate rare tumor cells in blood LMNTIC Biotech pioneers novel ...